Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Explore this paper's citation graph
Summary
In this review, the pharmacological treatment available against type 2 diabetes mellitus is discussed with particular emphasis on its impact on the endothelium.
- Type
- article
- Published
- 2009-01-15
- Cited by
- 55
- References
- 241
- OpenAlex
- https://openalex.org/W19038307
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:5408171
Keywords
Joint venture, Joint (building), Competition (biology), Business, Authorization
References
- Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans
- Atherosclerosis--an inflammatory disease.
- Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats.
- Tetrahydrobiopterin restores endothelial function in long-term smokers.
- Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?
- Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
- Comparison of the antioxidant and vascular effects of gliclazide and glibenclamide in Type 2 diabetic patients: a randomized crossover study.
- Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide.
- Effects of intensive glucose lowering in type 2 diabetes.
- Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study.
- Peroxisome Proliferator-Activated Receptor &ggr; Activators Inhibit Cardiac Hypertrophy in Cardiac Myocytes
- Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.
- Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.
- GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery.
- The hormone resistin links obesity to diabetes
- Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats.
- Free radicals mediate endothelial cell dysfunction caused by elevated glucose.
- Leptin induces oxidative stress in human endothelial cells
Cited by
- On anti-diabetic agents and the vasculature
- Studies on Incretins and Cardiovascular Function
- Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type‐2 diabetes
- Treating Coronary Disease and the Impact of Endothelial Dysfunction
- Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools
- Comparison of brachial artery flow‐mediated dilation in youth with type 1 and type 2 diabetes mellitus
- Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
- Significance of CXCL12 in Type 2 Diabetes Mellitus and Its Associated Complications
- Interleukin (IL)-10 Gene Polymorphisms Are Associated with Type 2 Diabetes With and Without Nephropathy: A Study of Patients from the Southeast Region of Iran
- Isolated unilateral disk edema
- In Vitro Glucose Entrapment and Alpha- Glucosidase Inhibition of Mucilaginous Substances from Selected Thai Medicinal Plants
- Pomegranate ellagitannins inhibit α-glucosidase activity in vitro and reduce starch digestibility under simulated gastro-intestinal conditions
- Immunomodulatory effects of oral antidiabetic drugs in lymphocyte cultures from patients with type 2 diabetes
- Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.
- Endothelial dysfunction - a major mediator of diabetic vascular disease.
- Hypoglycemic, hypolipidemic and antioxidant effects of Sarcandra glabra polysaccharide in type 2 diabetic mice.
- Oxidative stress and its association with TNF-α-308 G/C and IL-1α-889 C/T gene polymorphisms in patients with diabetes and diabetic nephropathy.
- Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients.
- Marrubiin, a constituent of Leonotis leonurus, alleviates diabetic symptoms.
- Oscillating high glucose enhances oxidative stress and apoptosis in human coronary artery endothelial cells
Related papers
- Joint Venture Agreements and EU Competition Law: The Case of the Construction Industry in Particular
- Realization of the Anticompetitive Potential of Joint Ventures in Bulgaria (1991-2010)
- On the Anti-Monopoly Analysis and Regulation of Joint Venture
- Uncompetitive joint ventures
- Competition Law in Australia 3rd ed
- FDI and EU Competition Law - Achieving Legal Certainty When Creating Korean-European Joint Ventures
- Innovation and competition policy
- Competition, cooperation and mergers: Economic and policy issues
- Economic analysis of the firm’s boundaries and the limits of competition: The case of Nord Stream 2 AG